NM_001029891.3:c.412A>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001029891.3(PGAM4):​c.412A>G​(p.Lys138Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

PGAM4
NM_001029891.3 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.87

Publications

0 publications found
Variant links:
Genes affected
PGAM4 (HGNC:21731): (phosphoglycerate mutase family member 4) This intronless gene appears to have arisen from a retrotransposition event, yet it is thought to be an expressed, protein-coding gene. The encoded protein is a member of the phosphoglycerate mutase family, a set of enzymes that catalyze the transfer of a phosphate group from 3-phosphoglycerate to 2-phosphoglycerate. [provided by RefSeq, May 2010]
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15175909).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PGAM4NM_001029891.3 linkc.412A>G p.Lys138Glu missense_variant Exon 1 of 1 ENST00000458128.3 NP_001025062.1 Q8N0Y7
ATP7ANM_000052.7 linkc.-21-2394T>C intron_variant Intron 1 of 22 ENST00000341514.11 NP_000043.4 Q04656-1B4DRW0Q762B6
ATP7ANM_001282224.2 linkc.-21-2394T>C intron_variant Intron 1 of 21 NP_001269153.1 Q04656-5B4DRW0Q762B6
ATP7ANR_104109.2 linkn.144-2394T>C intron_variant Intron 1 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PGAM4ENST00000458128.3 linkc.412A>G p.Lys138Glu missense_variant Exon 1 of 1 6 NM_001029891.3 ENSP00000412189.1 Q8N0Y7
ATP7AENST00000341514.11 linkc.-21-2394T>C intron_variant Intron 1 of 22 1 NM_000052.7 ENSP00000345728.6 Q04656-1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD2 exomes
AF:
0.0000165
AC:
3
AN:
182309
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000109
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000182
AC:
2
AN:
1098168
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
363580
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26397
American (AMR)
AF:
0.0000568
AC:
2
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54143
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
842077
Other (OTH)
AF:
0.00
AC:
0
AN:
46091
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 27, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.412A>G (p.K138E) alteration is located in exon 1 (coding exon 1) of the PGAM4 gene. This alteration results from a A to G substitution at nucleotide position 412, causing the lysine (K) at amino acid position 138 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
13
DANN
Benign
0.97
DEOGEN2
Benign
0.095
T
FATHMM_MKL
Benign
0.63
D
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
1.9
L
PhyloP100
1.9
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.25
Sift
Benign
0.18
T
Sift4G
Benign
0.29
T
Polyphen
0.024
B
Vest4
0.26
MutPred
0.46
Loss of ubiquitination at K138 (P = 0.0141);
MVP
0.80
MPC
0.76
ClinPred
0.082
T
GERP RS
0.12
PromoterAI
0.019
Neutral
Varity_R
0.26
gMVP
0.76
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781868948; hg19: chrX-77224724; API